Insider · CIK 0001237418
Jacob A Frenkel
Files at BCLI (BRAINSTORM CELL THERAPEUTICS INC.). First filing -, latest -.
In brief
Jacob A Frenkel files SEC Form 4 as director at BCLI (BRAINSTORM CELL THERAPEUTICS INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jacob A Frenkel has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 24, 2026 | BCLI BRAINSTORM CELL THERAPEUTICS INC. | AGrant or award Common Stock | +100,000 | $0.00 | $0 | 343,777 | Jul 28, 2026 |
| Feb 26, 2026 | BCLI BRAINSTORM CELL THERAPEUTICS INC. | AGrant or award Common Stock | +200,000 | $0.00 | $0 | 243,777 | May 29, 2026 |
| Jan 1, 2025 | BCLI BRAINSTORM CELL THERAPEUTICS INC. | AGrant or award Common Stock | +40,000 | $0.00 | $0 | 43,777 | Jan 3, 2025 |
Questions about Jacob A Frenkel
Answered from the filings on this page, as of the latest one.
Is Jacob A Frenkel buying or selling?
Jacob A Frenkel has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jacob A Frenkel's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jacob A Frenkel has 0.
Where does Jacob A Frenkel file Form 4?
Jacob A Frenkel has filed Form 4 at BCLI (BRAINSTORM CELL THERAPEUTICS INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.